ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO074

Cisplatin-Induced AKI: Preconditioning Protects by mRNA-Independent Proteome Alterations

Session Information

Category: Acute Kidney Injury

  • 103 AKI: Mechanisms

Authors

  • Späth, Martin, Department 2 of Internal Medicine, Renal Division; University of Cologne, Cologne, Germany
  • Bartram, Malte P., Department 2 of Internal Medicine, Renal Division; University of Cologne, Cologne, Germany
  • Palacio-Escat, Nicolàs, RWTH Aachen, Aachen, Germany
  • Hoyer, Karla Johanna ruth, Department 2 of Internal Medicine, Renal Division; University of Cologne, Cologne, Germany
  • Schermer, Bernhard, Department 2 of Internal Medicine, Renal Division; University of Cologne, Cologne, Germany
  • Benzing, Thomas, Department 2 of Internal Medicine, Renal Division; University of Cologne, Cologne, Germany
  • Burst, Volker Rolf, Department 2 of Internal Medicine, Renal Division; University of Cologne, Cologne, Germany
  • Saez-Rodriguez, Julio, RWTH Aachen, Aachen, Germany
  • Huesgen, Pitter F., Forschungszentrum Juelich, Juelich, Germany
  • Mueller, Roman-Ulrich, Department 2 of Internal Medicine, Renal Division; University of Cologne, Cologne, Germany
  • Rinschen, Markus M., Department 2 of Internal Medicine, Renal Division; University of Cologne, Cologne, Germany
Background


Acute kidney injury is one of the most common kidney diseases, resulting in significantly increased morbidity and mortality. Unfortunately, strategies for prevention or causal treatment are lacking in routine clinical practice. During the last years it has been shown in animal models, that a number of preconditioning protocols have a protective effect.

Methods


We characterized two of these strategies - calorie restriction and hypoxic preconditioning - in a mouse model of cisplatin-induced acute kidney injury. To investigate the underlying mechanisms, we used multi-layered omic data (transcriptome, proteome, and N-degradome for measuring proteolytic activity) and functional parameters of preconditioned and non-preconditioned cisplatin-treated animals. These parameters were generated from identical animals and integrated bioinformatically.

Results


Both protocols significantly reduced cisplatin-induced acute kidney injury. Bioinformatic analysis revealed mRNA-independent proteomic changes affecting the extracellular compartment, mitochondrial function and tubular transporters. Interestingly, our analyzes showed a strong dissociation of protein and mRNA expression after cisplatin treatment. In the animal cohort, the degree of mRNA-protein dissociation showed a strong correlation (R> 0.95) with the degree of damage. N-degradome analysis revealed that most post-transcriptional changes were determined by Arg-specific proteolytic processing. This involved a characteristic cisplatin-induced complement activation, which was prevented by preconditioning. In addition, amyloid and acute phase proteins accumulated within the cortical parenchyma. Extensive analyzes of damage-associated molecular patterns (DAMPs) suggest that the transcription-independent deposition of serum amyloid P could play a key role in the contribution of the microenvironment to renal damage.

Conclusion


This study provides new insights into the pathogenesis of cisplatin-induced acute kidney injury and the molecular mechanisms that underly organ protection through preconditioning through multi-omic phenotype correlations.